Jackson Michuda
Impact in
-
- PARP inhibition in cancer therapy
- Cancer Diagnosis and Treatment
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Cancer Diagnosis and Treatment 3
- PARP inhibition in cancer therapy 1
-
- Molecular Biology Techniques and Applications 1
- Metabolomics and Mass Spectrometry Studies 1
- CRISPR and Genetic Engineering 1
- Gene expression and cancer classification 1
- Co-authors
- Nike Beaubier (2 shared papers)Timothy Taxter (4 shared papers)Catherine Igartua (4 shared papers)Martin C. Stumpe (4 shared papers)Joshua S. K. Bell (3 shared papers)Bonnie V. Dougherty (1 shared paper)Jonathan R. Dry (1 shared paper)Andrew J. Sedgewick (1 shared paper)
- Journals
- Cancer Research (2 papers)Cancer Medicine (1 paper)Journal of Clinical Oncology (1 paper)Molecular Diagnosis & Therapy (1 paper)BMC Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Jackson Michuda
5 papers receiving 53 citations
Peers
Comparison fields: 5 of 19
- Oncology 39
- Cancer Research 21
- Oral Surgery 8
- Otorhinolaryngology 2
- Molecular Biology 30
Countries citing papers authored by Jackson Michuda
This map shows the geographic impact of Jackson Michuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jackson Michuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jackson Michuda more than expected).
Fields of papers citing papers by Jackson Michuda
This network shows the impact of papers produced by Jackson Michuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jackson Michuda. The network helps show where Jackson Michuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Jackson Michuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 28 | |
| 2 | 2023 | 18 | |
| 3 | 2022 | 7 | |
| 4 | 2023 | 2 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 0 |
About Jackson Michuda
Jackson Michuda is a scholar working on Oncology, Molecular Biology, Cancer Research, Surgery and Otorhinolaryngology, having authored 6 papers that have together received 56 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers), PARP inhibition in cancer therapy (1 paper), Molecular Biology Techniques and Applications (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper), CRISPR and Genetic Engineering (1 paper), Tumors and Oncological Cases (1 paper) and Gene expression and cancer classification (1 paper). The work is most often cited by research in Oncology (39 citations), Cancer Research (21 citations), Oral Surgery (8 citations), Otorhinolaryngology (2 citations) and Molecular Biology (30 citations). Jackson Michuda has collaborated with scholars based in United States. Frequent co-authors include Nike Beaubier, Timothy Taxter, Catherine Igartua, Martin C. Stumpe, Joshua S. K. Bell, Bonnie V. Dougherty, Jonathan R. Dry, Andrew J. Sedgewick, Joel T. Dudley and Kyle A. Beauchamp. Their work appears in journals such as Cancer Research, Cancer Medicine, Journal of Clinical Oncology, Molecular Diagnosis & Therapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.